can you take glp 1 with thyroid issues GLP-1RA and cancer: New study suggests detection bias, not causation Lots of questions regarding Thyroid

The more meaningful question is not: Do patients regain weight after stopping GLP-1s? It is: How should we transition patients from pharmacologic support to long-term weight maintenance? Obesity is a chronic disease

Tirzepatide is a GLP-1/GIP receptor agonist that has been studied in FDA-approved medications such as Mounjaro

A new solution with some downsides takes its place.

Discover how medically supervised GLP-1 (Trizepatide) injections at Waccamaw Med Spa can help you achieve safe and effective weight loss once and for all

The global incretin-based drugs market was valued at USD 39.4 billion in 2025 and is projected to grow from USD 41.6 billion in 2026 to USD 72.6 billion by 2035, expanding at a CAGR of 6.4% between 2026 and 2035, driven by the rising prevalence of type 2 diabetes mellitus.

Formulated for easy, consistent use, they fit seamlessly into your daily habits